In patients with NSTEMI undergoing PCI, high-risk HDL-C levels (<35 and >55 mg/dL) were associated with an increased risk of MACCE compared to low-risk levels (35-55 mg/dL) (OR 1.645).
Cohort (n=1,934)
Open-label
No
Is there a U-shaped association between HDL-C levels and cardiovascular events in patients with myocardial infarction undergoing PCI?
In patients with NSTEMI undergoing PCI, there is a U-shaped association between HDL-C levels and MACCE, with both very low and very high levels increasing cardiovascular risk.
Effect estimate: OR 1.645
Absolute Event Rate: 14.3% vs 9.7%
p-value: p=0.006
BACKGROUND: Studies in populations with or without cardiovascular disease have shown that very high HDL-C levels are associated with an increased risk of cardiovascular events. However, the exact relationship between HDL-C levels and long-term prognosis remains unknown in patients with myocardial infarction (MI) undergoing percutaneous coronary intervention (PCI). METHODS: This was a post hoc secondary analysis of long-term follow-up results in patients undergoing PCI open-label, observational cohort study. Patients with MI who had undergone PCI were enrolled. Restricted cubic spline (RCS) analysis and logistic regression analysis were performed to assess the relationship between HDL-C levels and the risk of cardiovascular events. RESULTS: A total of 1934 patients with MI undergoing PCI were enrolled in our analysis and our population was divided in 3 groups according to the HDL-C plasma levels: HDL-C 80 mg/dL (high HDL-C). RCS analysis showed a nonlinear U-shaped association between HDL-C levels and major adverse cardiac and cerebrovascular events (MACCE) in patients with NSTEMI with adjusted variables. After adjusting for potential confounders, the follow-up analysis indicated that high risk group had elevated occurrence of MACCE than low risk group (HDL-C 35 and 55 mg/dL) (OR:1.645, P = 0.006). CONCLUSIONS: Our analysis demonstrated that there is a U-shaped association between HDL-C and MACCE in patients with NSTEMI undergoing PCI.
Chen et al. (Mon,) conducted a cohort in Myocardial infarction (NSTEMI) undergoing PCI (n=1,934). High-risk HDL-C (< 35 and > 55 mg/dL) vs. Low-risk HDL-C (35-55 mg/dL) was evaluated on Major adverse cardiac and cerebrovascular events (MACCE) (OR 1.645, p=0.006). In patients with NSTEMI undergoing PCI, high-risk HDL-C levels (<35 and >55 mg/dL) were associated with an increased risk of MACCE compared to low-risk levels (35-55 mg/dL) (OR 1.645).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: